SEC Comment Letter for Bone Biologics Corp (BBLG, BBLGW) (CIK 0001419554) (BBLG) — May 11, 2015
Bone Biologics Corp (BBLG, BBLGW) (CIK 0001419554)
Date: May 11, 2015 · CIK: 0001419554 · Accession: 0000000000-15-025606
AI Filing Summary & Sentiment
Reasoning
Letter
May 11, 2015 Michael Schuler Chief Executive Officer Bone Biologics, Corp. 175 May Street, Suite 400 Edison, NJ 08837
Re: Bone Biologics, Corp. Amendment No. 1 to Re gistration Statement on Form S -1 Filed April 30, 2015 File No. 333 -200156
Dear Mr. Shuler :
We have reviewed your amended registration statement and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure.
Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.
After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments. Unless we note otherwise , our references to prior comments are to comments in our January 21, 2015 letter .
Selling Stockholders, page 44
1. Please revise the selling stockholder table to include the correct number of shares and percentag e of your outstanding shares that will be beneficially held by each selling stockholder following this offering. Please also clarify which shares of common stock being registered are underlying warrants, and, for each applicable selling stockholder, pleas e clearly disclose the natural person or persons who exercise the sole or shared voting and/or dispositive powers with respect to the shares to be offered by such stockholder.
Michael Shuler Bone Biologics, Corp. May 11, 2015 Page 2
Please contact Jennifer López, Staff Attorney, at (202) 551 -3792, Liz Walsh , Staff Attorney, at (202) 551 -3696 or met at (202) 551 -3720 with any other questions.
Sincerely,
/s/ Elizabeth C. Walsh for
Show Raw Text
May 11, 2015 Michael Schuler Chief Executive Officer Bone Biologics, Corp. 175 May Street, Suite 400 Edison, NJ 08837 Re: Bone Biologics, Corp. Amendment No. 1 to Re gistration Statement on Form S -1 Filed April 30, 2015 File No. 333 -200156 Dear Mr. Shuler : We have reviewed your amended registration statement and have the following comment . In our comment , we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information . If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment , we may have additional comments. Unless we note otherwise , our references to prior comments are to comments in our January 21, 2015 letter . Selling Stockholders, page 44 1. Please revise the selling stockholder table to include the correct number of shares and percentag e of your outstanding shares that will be beneficially held by each selling stockholder following this offering. Please also clarify which shares of common stock being registered are underlying warrants, and, for each applicable selling stockholder, pleas e clearly disclose the natural person or persons who exercise the sole or shared voting and/or dispositive powers with respect to the shares to be offered by such stockholder. Michael Shuler Bone Biologics, Corp. May 11, 2015 Page 2 Please contact Jennifer López, Staff Attorney, at (202) 551 -3792, Liz Walsh , Staff Attorney, at (202) 551 -3696 or met at (202) 551 -3720 with any other questions. Sincerely, /s/ Elizabeth C. Walsh for Mara L. Ransom Assistant Director